Bell; Robert G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bell; Robert G..The latest application filed is for "intranasal epinephrine formulations and methods for the treatment of disease".

Company Profile

5.10.13

Bell; Robert G. - San Diego CA
Bell; Robert G. - Palm Harbor FL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intranasal epinephrine formulations and methods for the treatment of disease Grant 11,191,838 - Lowenthal , et al. December 7, 2	2021-12-07
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease App 20210361770 - LOWENTHAL; Richard ; et al.	2021-11-25
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease App 20200261582 - LOWENTHAL; Richard ; et al.	2020-08-20
Intranasal epinephrine formulations and methods for the treatment of disease Grant 10,682,414 - Lowenthal , et al.	2020-06-16
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease App 20190269781 - LOWENTHAL; Richard ; et al.	2019-09-05
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease App 20190269782 - LOWENTHAL; Richard ; et al.	2019-09-05
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease App 20190269780 - LOWENTHAL; Richard ; et al.	2019-09-05
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Grant 8,680,084 - Bell , et al. March 25, 2	2014-03-25
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Grant 8,338,396 - Bell , et al. December 25, 2	2012-12-25
Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology App 20120322777 - Bell; Robert G. ; et al.	2012-12-20
Methods Of Hormonal Treatment Utilizing Contraceptive Regimens With Continuous Estrogen Administration App 20110124611 - BELL; ROBERT G. ; et al.	2011-05-26
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Grant 7,858,605 - Bell , et al. December 28, 2	2010-12-28
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration Grant 7,855,190 - Bell , et al. December 21, 2	2010-12-21
Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology App 20100298279 - BELL; Robert G. ; et al.	2010-11-25
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Grant 7,615,545 - Bell , et al. November 10, 2	2009-11-10
Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology App 20080132473 - Bell; Robert G. ; et al.	2008-06-05
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology App 20080064670 - Bell; Robert G. ; et al.	2008-03-13
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Grant 7,320,969 - Bell , et al. January 22, 2	2008-01-22
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration App 20050143359 - Bell, Robert G. ; et al.	2005-06-30
Method for treating osteoporosis in castrated prostatic cancer patients Grant 6,613,758 - Bell September 2, 2	2003-09-02
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology App 20030139381 - Bell, Robert G. ; et al.	2003-07-24
Method For Treating Osteoporosis In Castrated Prostatic Cancer Patients App 20010041699 - BELL, ROBERT G.	2001-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.